Although we identified that CIP2A acts as an oncoprotein in the CRC tissues compared to normal tissues, using IHC in 2013, the underlying mechanisms of its function in the development of CRC were not entirely clear [15]. The gene discussed is CIP2A; the disease is colorectal carcinoma.